MILLENNIUM MANAGEMENT LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1273087
NEW YORK, NY
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,750,038
-$11,569,052 QoQ
Shares Held
140,595
-69.4% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Derivatives in VRDN
reported options exposure · as of Jun 30, 2023CallValue
$713,700
CallShares
30,000
PutValue
$2,509,845
PutShares
105,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. VRDN ranks #226 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in VRDN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,750,038 | 140,595 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,319,090 | 460,125 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,940,922 | 136,280 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $830,915 | 59,436 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,016,581 | 297,966 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,015,683 | 365,972 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,197,819 | 668,036 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,968,647 | 228,182 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $358,447 | 20,471 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,895,904 | 224,789 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,179,171 | 1,380,650 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,825,976 | 1,337,788 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $713,700 | 30,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,509,845 | 105,500 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $15,622,424 | 614,089 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,640,584 | 90,400 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $22,954,795 | 785,854 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,629,850 | 762,060 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,028,803 | 1,126,085 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,039,176 | 975,618 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,141,450 | 462,390 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,654,125 | 161,345 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,153,007 | 117,715 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $721,470 | 43,176 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||